TT-302

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTT-302
Drug Alias Nameactivated glial-associated cytokine release inhibitor (Northwestern University/Neuromedix)MW01-7-084WHTT-302MW-084
ClassificationSmall molecules
Mechanisms of ActionCytokine synthesis inhibitorsCNS modulatorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseCentral Nervous System DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuro Medix IncTransition Therapeutics IncNorthwestern University
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseCentral Nervous System DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A